DOMINIQUE GRIFFIN: Open Payments
NPI 1518706167 · PASADENA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 16 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $72 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $184 |
| Astellas Pharma US Inc | 3 | $58 |
| Exact Sciences Corporation | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
| GlaxoSmithKline, LLC. | 1 | $29 |
Products named: Ozempic, Rybelsus, Veozah, MOUNJARO, SHINGRIX, The Cologuard Plus Collection Kit, Cologuard Collection Kit.
Industry payments across MD — which companies pay providers there.
